Loading...
Pharmaceutical Approval Update
Elotuzumab (Empliciti) and ixazomib (Ninlaro) for some multiple myeloma patients; Fluad (influenza vaccine, adjuvanted) for immunization of persons 65 years of age and older; and osimertinib (Tagrisso) for certain non–small-cell lung cancers
Na minha lista:
| Udgivet i: | P T |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MediMedia USA, Inc.
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4699482/ https://ncbi.nlm.nih.gov/pubmed/26766887 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|